Results 11 to 20 of about 11,911,230 (418)
Subcutaneous injection of a low volume (100 mg/mL) formulation is an attractive administration strategy for monoclonal antibodies (mAbs) and other biopharmaceutical proteins.
Jack E. Bramham+3 more
doaj +1 more source
Background and objectives: Even though many industrially manufactured medicines are available, extemporaneous preparations still have their niche in dermatology.
Olga Kiseļova+2 more
doaj +1 more source
Preferential interactions of excipients with the antibody surface govern their effect on the stability of antibodies in solution. We probed the preferential interactions of proline, arginine.HCl (Arg.HCl), and NaCl with three therapeutically relevant ...
Theresa K. Cloutier+4 more
doaj +1 more source
Background and Objectives: A comparative survey of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients was carried out in three countries, with the aim of identifying appropriate policy measures designed to alleviate the burden of ...
Elenka Brenna+2 more
doaj +1 more source
Weak macromolecular interactions assume a dominant role in the behavior of highly concentrated solutions, and are at the center of a variety of fields ranging from colloidal chemistry to cell biology, neurodegenerative diseases, and manufacturing of ...
Arun Parupudi+8 more
doaj +1 more source
Peptide therapeutics are increasingly used in the treatment of disease, but their administration by injection reduces patient compliance and convenience, especially for chronic diseases.
Sergei Pechenov+13 more
doaj +1 more source
Discovering Novel Small Molecule Compound for Prevention of Monoclonal Antibody Self-Association
Designing an antibody with the desired affinity to the antigen is challenging, often achieved by lengthening the hydrophobic CDRs, which can lead to aggregation and cause major hindrance to the development of successful biopharmaceutical products ...
Lok Hin Lui+3 more
doaj +1 more source
Background and Objectives: We have conducted a survey of academic and clinical experts who are participants in the European ME/CFS Research Network (EUROMENE) to elicit perceptions of general practitioner (GP) knowledge and understanding of myalgic ...
John Cullinan+10 more
doaj +1 more source
Background and objectives: Extemporaneous preparations are pharmaceutical preparations individually prepared for a specific patient or patient group, but also high-risk products accompanied by doubts regarding their safety and quality.
Olga Kiseļova+3 more
doaj +1 more source
Design of targeted dosage form of ofloxacin+ [PDF]
The targeted pro-drug is a classical pro-drug design often representing a non-specific chemical approach to mask undesirable drug properties, such as limited bioavailability, lack of site specificity, and chemical instability. On the other hand, targeted
Shahar Yar M.+3 more
doaj +3 more sources